Benchmark Reiterates Buy on Imax, Maintains $22 Price Target
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Mike Hickey reiterates a Buy rating on Imax (NYSE:IMAX) and maintains a $22 price target.
April 26, 2024 | 4:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Benchmark analyst Mike Hickey reiterates a Buy rating on Imax and maintains a $22 price target.
The reiteration of a Buy rating and maintenance of a $22 price target by a Benchmark analyst could positively influence investor sentiment towards IMAX, potentially driving its stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100